Caio Cesar Candido

Mrs. Caio Cesar Candido

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
ANAmanda Alvim Negreti
Amanda Alvim Negreti
GFGuilherme Álvaro Ferreira-Silva
Guilherme Álvaro Ferreira-Silva
CPCarolina Girotto Pressete
Carolina Girotto Pressete
RFRafael Fonseca
Rafael Fonseca
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
MIMarisa Ionta
Marisa Ionta
Melanoma is a highly aggressive skin cancer with a limited targeted therapy arsenal. Ruthenium-based complexes have shown interesting pro-apoptotic effects on malignant tumor cell lines. In this study three ruthenium(II) complexes containing cinnamic acid derivatives as ligands were synthesized and characterized and their cytotoxic profile was evaluated on four melanoma cell lines (HT-144, SK-MEL-147, CHL-1, and WM1366). All complexes significantly reduced cell viability in a concentration-dependent manner. However, complex (2) bearing trans-4-(trifluoromethyl)cinnamic acid as the ligand was the most promising compound. We demonstrated that complex (2) inhibits cell cycle progression at the G1 phase and induces apoptosis in the CHL-1 cell line. Our data showed that cell cycle arrest at G1/S transition was, at least in part, due to reduction of ERK activation, CDKN1A (p21) upregulation and CCNE2 (cyclin E2) downregulation. Moreover, pro-apoptotic activity of complex (2) was ascribed to its ability to modulate BAX and Bcl-2 expression profiles leading to an increase in the BAX/Bcl-2 ratio. We also demonstrated that complex (2) affects the actin cytoskeleton organization pattern and inhibits the migration of CHL-1. Taken together, the data indicate the promising antitumor potential of complex (2) against melanoma cells and support further in vivo studies.

1 June 2020 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
JDJúlia Scaff Moreira Dias
Júlia Scaff Moreira Dias
HSHenrique Vieira Reis Silva
Henrique Vieira Reis Silva
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
GSGuilherme Álvaro Ferreira da Silva
Guilherme Álvaro Ferreira da Silva
MIMarisa Ionta
Marisa Ionta
ADAntônio Carlos Doriguetto
Antônio Carlos Doriguetto

6 October 2022 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
HSHenrique Vieira Reis Silva
Henrique Vieira Reis Silva
BZBruno Zavan
Bruno Zavan
MIMarisa Ionta
Marisa Ionta
MBMarília Imaculada Frazão Barbosa
Marília Imaculada Frazão Barbosa
Antonio Carlos DoriguettoAntonio Carlos Doriguetto
Antonio Carlos Doriguetto

1 July 2025 in ACS Omega
Verified
Journal Article
Open access
GFGuilherme Ferreira-Silva
Guilherme Ferreira-Silva
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
GGGraciana Yokota Garavelli
Graciana Yokota Garavelli
CPCarolina Girotto Pressete
Carolina Girotto Pressete
ECEster Siqueira Caixeta
Ester Siqueira Caixeta
AAAlexandre Ferro Aissa
Alexandre Ferro Aissa
Lung cancer is the leading cause of cancer-related deaths globally, with nonsmall cell lung cancer (NSCLC) being the most prevalent type. Cisplatin and its derivatives are commonly used in classical chemotherapy, but their therapeutic efficacy is limited, and they came with significant side effects. The targeted therapies and immunotherapy have improved survival rates for certain groups of patients. However, overall survival for NSCLC remains very low, which contributes to the high mortality rate. Thus, the search for effective and affordable drugs is ongoing. In this context, ruthenium-based complexes have been extensively studied as promising anticancer agents. In our previous studies, three ruthenium­(II) complexes containing cinnamic acid derivatives with ligands were synthesized and characterized. We demonstrated that the complex [Ru­(trans-4-(trifluoromethyl)­cinnam)­(dppb)­(bipy)]­PF6 effectively inhibited the proliferation of melanoma cells with either an activating N-Ras mutation or a TP53 inactivation mutation. Therefore, in this study, we aimed to evaluate the antitumor potential of complex [Ru­(3,4-cinnam)­(dppb)­(bipy)]­PF6, named CINNAM, against nonsmall cell lung cancer cells A549 (TP53 wild type; K-Ras mutated) and H1299 (TP53 mutated; N-Ras mutated). CINNAM selectively targeted cancer cells over normal cells, with A549 cells showing higher sensitivity to the CINNAM compared to H1299 cells. CINNAM effectively reduced the proliferation of A549 cells by inducing cell cycle arrest at the G0/G1 phase. CINNAM modulated the expression profiles of key cell cycle regulators, CDKN1A, CCND1, and CCNE2. Further, we demonstrated that the cytotoxic activity of CINNAM is linked to its pro-oxidant and pro-apoptotic properties. The interactions of the complex with ct-DNA (calf thymus DNA) were analyzed, and based on the Kb value, the complex present intermediate affinity for DNA. In conclusion, CINNAM exhibits potent antiproliferative and pro-apoptotic effects on NSCLC cells, surpassing those observed with cisplatin.

30 November 2024 in Magnetochemistry
Verified
Journal Article
Open access
PDF file
JTJésio Daniel Tempesta
Jésio Daniel Tempesta
FPFabio Faria Paiva
Fabio Faria Paiva
LFLeonildo A. Ferreira
Leonildo A. Ferreira
Rafaela RibeiroRafaela Ribeiro
Rafaela Ribeiro
LBLuckerman Duarte Gonçalves Botelho
Luckerman Duarte Gonçalves Botelho
MMMaria Vanda Marinho
Maria Vanda Marinho
The heterobimetallic 15-MC-5 metallacrown of formula [CeCu5(5mpzHA)5(NO3)(H2O)7]·2NO3·7H2O, designated MC-Ce, was synthesized using 5-methyl-2-pyrazinehydroxamic acid (5mpzHA) as a linker, reacting with CeIII and CuII salts under mild conditions. Single-crystal X-ray diffraction analysis reveals a crown-like [Cu5Ce(5mpzHA)5] core, characteristic of a 15-MC-5 system, with five CuII atoms at the rim of the crown and the CeIII ion occupying the dome of the crown, with water molecules, oxygen atoms and one nitrate anion filling the nine-coordination sphere around the CeIII ion, which exhibits a distorted spherical tricapped trigonal prism geometry. The thermogravimetric analysis evidences successive mass losses due to the removal of water molecules and decomposition of the structure after 217 °C, whereas the PXRD analysis of the thermal decomposition residue reveals the presence of copper and copper/cerium oxide particles. These nanocomposite materials were also synthesized using the metallacrown MC-Ce under a hydrothermal method in the presence of multi-walled carbon nanotubes (MWCNTs), affording insights that this metallacrown can act as a source precursor for the synthesis of these mixed cerium/copper oxide nanomaterials. The experimental χMT value in MC-Ce at room temperature is 3.175 cm3 mol−1 K, which is higher than the calculated one for one magnetically isolated CeIII plus five CuII ions, probably due to the antiferromagnetic interactions among CuII ions within the metallacrown hoop plus the thermal depopulation of JZ sublevels of CeIII ground state (5/2), which exhibit a small splitting under the anisotropic ligand field effects. The χMT decreases continuously until it reaches the value of 0.80 cm3 mol−1 K at 10 K, reinforcing the presence of intramolecular antiferromagnetic interactions.